Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study
单中心回顾性研究表明,异基因造血干细胞移植前短期高剂量阿糖胞苷巩固治疗可改善急性髓系白血病患者的2年无复发生存期,但不能改善总生存期。
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06734-6
Ma, Yu; Cheng, Yanyan; Sun, Yuting; Zhu, Xiaotong; Zhang, Huifang; Dhurel, Raj Singh; Zhang, Huanxin; Sun, Qian; Liu, Qiong; Chen, Wei; Cheng, Hai; Li, Zhenyu; Pan, Bin; Yan, Zhiling